In Vitro Diagnostics Global Market Report 2022: Capacity to Catch and Treat Disease Early Driving Adoption - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "In Vitro Diagnostics Market, by Product Type, by Technology, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.

In vitro diagnostic can be described as the reagents, instruments and systems intended for the diagnosis of disease or other conditions, including the determination of health status, in order to cure, alleviate, treat or prevent disease or its consequences. These products are intended for collection, processing and analysis of samples taken from the human body. They are used for taking and examining biological samples such as blood, saliva or tissue. Samples can be taken from the nose or throat, or from a vein or fingertip.

In recent years, the value of IVDs has gained increasing recognition due to their potential to save lives through earlier diagnosis of disease. The use of IVDs to predict underlying genetic diseases in addition to diagnostic screening can also prevent unnecessary patient suffering and reduce the amount of treatment required.

Market Dynamics

Increasing adoption of inorganic growth strategies by key players in market such as collaboration is expected to drive market growth over the forecast period.

For instance, in July 2022, ELITechGroup, manufacturer and distributors of in vitro diagnostic equipment and reagents for clinical chemistry, microbiology, molecular diagnostics, hematology, cytology, and sweat test systems and InfanDx AG, developing diagnostic solutions for acute and critical care conditions in newborns, announced at the ongoing 2022 AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, Illinois, U.S., the signing of a Memorandum of Understanding (MoU) to collaborate on the development and manufacturing of InfanDx' HypoxE Test for ELITechGroup's family of Selectra Pro clinical chemistry analyzers.

The parties intend to enter into a formal collaboration agreement once the biomarkers targeted by InfanDx' HypoxE Test are validated in patients from the recently closed Biomarkers And Neurological Outcome in Neonates (BANON) cohort study.

Key features of the study:

• This report provides an in-depth analysis of the global In-vitro diagnostics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global In-vitro diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global In-vitro diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global In-Vitro diagnostics market

Detailed Segmentation: Global In-Vitro Diagnostics Market, By Product Type:

• Instruments
• Reagents & Kits
• Blocking Buffers
• Proteins
• Secondary Antibodies
• Substrates
• Others

Global In-Vitro Diagnostics Market, By Technology:

• Immunoassay
• Clinical Chemistry
• Molecular Diagnostics
• Microbiology
• Hematology
• Coagulation & Hemostasis
• Urinalysis
• Others

Global In-Vitro Diagnostics Market, By Application:

• Infectious Diseases
• Diabetes
• Oncology
• Cardiology
• Nephrology
• Autoimmune Disorders
• Others

Global In-Vitro Diagnostics Market, By End User:

• Hospital
• Pathology Laboratories
• Point-of-Care Diagnostics
• Research Institutes
• Others

Global In-Vitro Diagnostics Market, By Region

Company Profiles

• Siemens Healthineers
• Sysmex Corporation
• Bio-Rad Laboratories
• BioMerieux S.A.
• Becton Dickinson, and Company
• Danaher Corporation
• Abbott Laboratories
• Hoffmann-la Roche Ltd
• QIAGEN N.V.
• Arkray, Inc.
• Nittobo Medical Co., Ltd.
• Medical & Biological Laboratories Co., Ltd.
• Miraca Holdings Inc.
• Mizuho Medy Co., Ltd.

Key Topics Covered:

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global In-Vitro Diagnostics Market- Impact of Coronavirus (Covid-19) Pandemic

5. Global In-Vitro Diagnostics Market, By Product Type, 2017 - 2030, (US$ Million)

6. Global In-Vitro Diagnostics Market, By Technology, 2017 - 2030, (US$ Million)

7. Global In-Vitro Diagnostics Market, By Application, 2017 - 2030, (US$ Million)

8. Global In-Vitro Diagnostics Market, By Region, 2017 - 2030, (US$ Million)

9. Competitive Landscape

10. Section

Companies Mentioned

• Siemens Healthineers
• Sysmex Corporation
• Bio-Rad Laboratories
• BioMerieux S.A.
• Becton Dickinson, and Company
• Danaher Corporation
• Abbott Laboratories
• Hoffmann-la Roche Ltd
• QIAGEN N.V.
• Arkray, Inc.
• Nittobo Medical Co., Ltd.
• Medical & Biological Laboratories Co., Ltd.
• Miraca Holdings Inc.
• Mizuho Medy Co., Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/7nc9fq